164 related articles for article (PubMed ID: 26397379)
21. Underlying Inborn Errors of Immunity in Patients With Evans Syndrome and Multilineage Cytopenias: A Single-Centre Analysis.
Miano M; Guardo D; Grossi A; Palmisani E; Fioredda F; Terranova P; Cappelli E; Lupia M; Traverso M; Dell'Orso G; Corsolini F; Beccaria A; Lanciotti M; Ceccherini I; Dufour C
Front Immunol; 2022; 13():869033. PubMed ID: 35655776
[TBL] [Abstract][Full Text] [Related]
22. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases.
Dufour JF; Pradat P; Ruivard M; Hot A; Dumontet C; Broussolle C; Trepo C; Sève P
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):245-53. PubMed ID: 19279468
[TBL] [Abstract][Full Text] [Related]
23. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
24. [Evans' syndrome: a retrospective study from the ship (French Society of Pediatric Hematology and Immunology) (36 cases)].
Blouin P; Auvrignon A; Pagnier A; Thuret I; Antoni G; Bader-Meunier B; Le Deist F; Chastagner P; Aladjidi N; Pellier I; Bertrand Y; Behar C; Landmann-Parker J; Leverger G; Perel Y
Arch Pediatr; 2005 Nov; 12(11):1600-7. PubMed ID: 16185853
[TBL] [Abstract][Full Text] [Related]
25. Comparison of immune manifestations between refractory cytopenia of childhood and aplastic anemia in children: A single-center retrospective study.
Wu J; Cheng Y; Zhang L
Leuk Res; 2015 Dec; 39(12):1347-52. PubMed ID: 26427728
[TBL] [Abstract][Full Text] [Related]
26. The association between immunodeficiency and the development of autoimmune disease.
Sleasman JW
Adv Dent Res; 1996 Apr; 10(1):57-61. PubMed ID: 8934926
[TBL] [Abstract][Full Text] [Related]
27. [Autoimmune neutropenias].
Lamy T
Rev Prat; 2001 Sep; 51(14):1552-7. PubMed ID: 11757271
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune manifestations in primary immune deficiencies.
Bussone G; Mouthon L
Autoimmun Rev; 2009 Feb; 8(4):332-6. PubMed ID: 19028607
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at middle anatolia.
Patiroglu T; Gungor HE; Unal E
Acta Microbiol Immunol Hung; 2012 Sep; 59(3):343-53. PubMed ID: 22982638
[TBL] [Abstract][Full Text] [Related]
30. Evans Syndrome as First Manifestation of Primary Immunodeficiency in Clinical Practice.
Martínez-Valdez L; Deyà-Martínez A; Giner MT; Berrueco R; Esteve-Solé A; Juan M; Plaza-Martín AM; Alsina L
J Pediatr Hematol Oncol; 2017 Oct; 39(7):490-494. PubMed ID: 28937520
[TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
[TBL] [Abstract][Full Text] [Related]
32. Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders.
Lehman HK
Curr Allergy Asthma Rep; 2015 Sep; 15(9):53. PubMed ID: 26233425
[TBL] [Abstract][Full Text] [Related]
33. Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency).
Berthet F; Le Deist F; Duliege AM; Griscelli C; Fischer A
Pediatrics; 1994 Feb; 93(2):265-70. PubMed ID: 8121739
[TBL] [Abstract][Full Text] [Related]
34. Management of chronic immune thrombocytopenia in children and adolescents: lessons from an Austrian national cross-sectional study of 81 patients.
Sipurzynski J; Fahrner B; Kerbl R; Crazzolara R; Jones N; Ebetsberger G; Jauk B; Strenger V; Wohlmuther B; Schwinger W; Lackner H; Urban C; Holter W; Minkov M; Kager L; Benesch M; Seidel MG
Semin Hematol; 2016 Apr; 53 Suppl 1():S43-7. PubMed ID: 27312164
[TBL] [Abstract][Full Text] [Related]
35. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies.
Azizi G; Tavakol M; Rafiemanesh H; Kiaee F; Yazdani R; Heydari A; Abouhamzeh K; Anvari P; Mohammadikhajehdehi S; Sharifia L; Bagheri Y; Mohammadi H; Abolhassani H; Aghamohammadi A
Expert Rev Clin Immunol; 2017 Nov; 13(11):1099-1106. PubMed ID: 29019451
[TBL] [Abstract][Full Text] [Related]
36. An autoimmune lymphoproliferative syndrome initially diagnosed as Evans syndrome.
Uysal Z; Ertem M; Talia İleri D; Doğu F; Azık FM; İkincioğulları A; Gözdaşoğlu S
Turk J Haematol; 2007 Jun; 24(2):80-4. PubMed ID: 27263622
[TBL] [Abstract][Full Text] [Related]
37. Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome.
Rao VK
Front Pediatr; 2015; 3():65. PubMed ID: 26258116
[TBL] [Abstract][Full Text] [Related]
38. Multilineage Immune-Mediated Cytopenias in Childhood: A Report of Five Patients.
Canpolat C; Culbert S; Zietz H; Hoots K
Turk J Haematol; 2000 Mar; 17(1):13-22. PubMed ID: 27265758
[TBL] [Abstract][Full Text] [Related]
39. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
40. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
El-Hallak M; Binstadt BA; Leichtner AM; Bennett CM; Neufeld EJ; Fuhlbrigge RC; Zurakowski D; Sundel RP
J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
